These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6173558)

  • 61. The host defense system in the human newborn: the role of interferon and the natural killer cell.
    Read SE; Williams BR
    Clin Invest Med; 1984; 7(4):259-62. PubMed ID: 6085299
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Antagonistic effects of interferons on the cytotoxicity mediated by natural killer cells.
    Trinchieri G; Santoli D; Granato D; Perussia B
    Fed Proc; 1981 Oct; 40(12):2705-10. PubMed ID: 6169557
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Interferon induction and augmentation of natural-killer activity by Staphylococcus protein A.
    Ratliff TL; McCool RE; Catalona WJ
    Cell Immunol; 1981 Jan; 57(1):1-12. PubMed ID: 6163551
    [No Abstract]   [Full Text] [Related]  

  • 64. Increased resistance to non-MHC-restricted cytotoxicity related to HLA A, B expression. Direct demonstration using beta 2-microglobulin-transfected Daudi cells.
    Quillet A; Presse F; Marchiol-Fournigault C; Harel-Bellan A; Benbunan M; Ploegh H; Fradelizi D
    J Immunol; 1988 Jul; 141(1):17-20. PubMed ID: 3288697
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Natural killing in estrogen-treated mice responds poorly to poly I.C despite normal stimulation of circulating interferon.
    Seaman WE; Merigan TC; Talal N
    J Immunol; 1979 Dec; 123(6):2903-5. PubMed ID: 227961
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Mode of regulation of natural killer cell activity by interferon.
    Minato N; Reid L; Cantor H; Lengyel P; Bloom BR
    J Exp Med; 1980 Jul; 152(1):124-37. PubMed ID: 6156979
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Medullasin enhances human natural killer cell activity by a mechanism other than the induction of interferons or interleukin-2.
    Aoki Y; Fukuchi K
    Jpn J Cancer Res; 1987 Jan; 78(1):68-73. PubMed ID: 2434455
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Spontaneous production of T (type II) interferon by a murine reticulum-cell sarcoma.
    Ponzio NM; Fitzgerald KL; Vilcek J; Thorbecke GJ
    Ann N Y Acad Sci; 1980; 350():157-67. PubMed ID: 6165270
    [No Abstract]   [Full Text] [Related]  

  • 69. Natural killer and killer cell activities in patients with primary immunodeficiencies or defects in immune interferon production.
    Lipinski M; Virelizier JL; Tursz T; Griscelli C
    Eur J Immunol; 1980 Apr; 10(4):246-9. PubMed ID: 6156843
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Natural killer cells in autoimmune diseases].
    Shparyk IaV; Stekhnovich IV
    Vrach Delo; 1991 Aug; (8):12-20. PubMed ID: 1719702
    [No Abstract]   [Full Text] [Related]  

  • 71. [In vitro cytotoxic activity of peripheral blood lymphocytes in patients with multiple sclerosis. Preliminary report].
    Czernicki J; Pacześniak J; Maciejek Z
    Neurol Neurochir Pol; 1983; 17(6):633-8. PubMed ID: 6669208
    [TBL] [Abstract][Full Text] [Related]  

  • 72. HLA-B12 antigen and multiple sclerosis in a Spanish population (Canary Islands).
    Gantes M; González T
    Tissue Antigens; 1983 Aug; 22(2):172-3. PubMed ID: 6623453
    [No Abstract]   [Full Text] [Related]  

  • 73. A model of the role of natural killer cells in immune surveillance--II.
    Merrill SJ
    J Math Biol; 1983; 17(2):153-62. PubMed ID: 6193212
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Signal slitting as a basis of involvement of the natural cytotoxicity system into endogenous biological relay].
    Cheknev SB
    Biull Eksp Biol Med; 1999 Dec; 128(12):604-12. PubMed ID: 10650453
    [No Abstract]   [Full Text] [Related]  

  • 75. Interferon in multiple sclerosis.
    Färkkilä M; Iivanainen M
    Clin Neuropharmacol; 1988 Apr; 11(2):120-9. PubMed ID: 2454155
    [No Abstract]   [Full Text] [Related]  

  • 76. Properties of mouse immune T-interferon (type II).
    Falcoff E; Wietzerbin J; Stefanos S; Lucero M; Billardon C; Catinot L; Besançon F; Ankel H
    Ann N Y Acad Sci; 1980; 350():145-56. PubMed ID: 6165269
    [No Abstract]   [Full Text] [Related]  

  • 77. Natural killing can be independent of interferon generated in vitro.
    Copeland CS; Koren HS; Jensen PJ
    Cell Immunol; 1981 Jul; 62(1):220-5. PubMed ID: 6167371
    [No Abstract]   [Full Text] [Related]  

  • 78. Immunoregulatory properties of type-I interferons: relevance to multiple sclerosis and the hypereosinophilic syndrome.
    Bartholomé EJ; Roufosse FE
    Acta Clin Belg; 1997; 52(6):350-9. PubMed ID: 9489130
    [No Abstract]   [Full Text] [Related]  

  • 79. Enhancing natural killer cells is beneficial in multiple sclerosis - No.
    Liu Q; Shi FD
    Mult Scler; 2019 Apr; 25(4):512-513. PubMed ID: 30421642
    [No Abstract]   [Full Text] [Related]  

  • 80. Enhancing natural killer cells is beneficial in multiple sclerosis - Yes.
    Laroni A
    Mult Scler; 2019 Apr; 25(4):510-512. PubMed ID: 30421641
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.